Daniel Ambinder, MD

• City University of New York – Queens College, Pre-Medical Coursework, 2009
• Touro College, BA, 2009
• University of Maryland School of Medicine, MD, 2014
• The Johns Hopkins Hospital, Internal Medicine Residency, 2017
• The Johns Hopkins Hospital, Cardiology Fellowship, 2020
• The Johns Hopkins Hospital, Interventional Cardiology Fellowship, 2021
• The Johns Hopkins Hospital, Structural Heart Disease Fellowship, 2022

Daniel I. Ambinder, MD, FACC, is an interventional and structural cardiologist at the University of Maryland St. Joseph Medical Center and a Visiting Assistant Professor of Medicine at the University of Maryland School of Medicine. He also holds an appointment as an Adjunct Assistant Professor in Medicine at the Johns Hopkins School of Medicine.

Dr. Ambinder earned his medical degree summa cum laude from the University of Maryland School of Medicine. He completed residency training in the Osler Program at The Johns Hopkins Hospital, followed by general cardiology, interventional cardiology, and structural heart disease fellowships at Johns Hopkins.

His clinical expertise includes complex coronary and valvular heart disease, cardiac arrest resuscitation, and mechanical circulatory support, and he maintains a comprehensive interventional practice.

A committed educator, Dr. Ambinder is the co-founder of CardioNerds (www.cardionerds.com), an internationally recognized cardiovascular education platform. He helped establish its programs in digital scholarship, narratives in cardiology, and medical journalism. He teaches in the University of Maryland medical student curriculum and has received multiple teaching awards, including the Johns Hopkins Department of Medicine Fellow Teaching Award, the Bayview Fellow Teaching Award, and the Critical Care PA Program Teaching Award. His scholarly work has also been recognized with the 2022 Top Principal Investigator Award from the Heart Failure Collaboratory and HFSA.

Angina, Aortic stenosis, Atrial septal defects, Bifurcation blockage, Carotid artery disease, Coronary aneurysm, Heart attack, Hypertrophic cardiomyopathy, Ischemic cardiomyopathy, Mitral valve stenosis, Mitral valve regurgitation, Patent foramen ovale, Angiography, Angioplasty, Atherectomy, Balloon mitral valvotomy, Coronary artery atherectomy, Coronary balloon angioplasty (PTCA), Coronary intervention, Endovascular patent foramen ovale (PFO) closure, Fractional flow reserve (FFR) determination, Heart imaging, Heart valve disease – percutaneous interventions, Intra-aortic balloon pumping, Percutaneous valve treatment, Pericardiocentesis, Rotational atherectomy, Stents, Left atrial appendage (LAA) closure (Watchman), Transcatheter edge-to-edge repair (TEER), MitraClip

1. Ambinder DI, Patil KD, Kadioglu H, Wetstein PS, Tunin RS, Fink SJ, Agnetti G, Halperin HR. (2021) Pulseless electrical activity as the initial cardiac arrest rhythm: importance of preexisting left ventricular function. Journal of the American Heart Association. 10(13):e018671. PMCID: PMC8403333.

2. Ambinder DI, Oberdier MT, Miklin DJ, Halperin HR. (2020) CPR and ECMO: The next frontier. Rambam Maimonides Medical Journal. 11(2):e0013. PMCID: PMC7202447.

3. Ambinder DI, Lum YW, Johnston PV. (2021) Percutaneous repair of iatrogenic arteriovenous fistula involving left internal mammary artery graft to LAD. JACC: Cardiovascular Interventions. 14(17):e223–e225. PMID: 34391712.

4. Oberdier MT, Li J, Ambinder DI, Suzuki M, Tumarkin E, Fink S, Neri L, Zhu X, Justice CN, Vanden Hoek TL, Halperin HR. (2024) Survival and neurologic outcomes from pharmacologic peptide administration during cardiopulmonary resuscitation of pulseless electrical activity. Journal of the American Heart Association. 13(13):e09757. PMCID: PMC11255698.

5. Goyal A, Ambinder D, Farr M. (2022) Collab, virtualize, democratize: A conversation with the founders of CardioNerds. Circulation. 146(4):269–275. PMID: 35877836.